A0A2I2ZRM9 (A0A2I2ZRM9_GORGO) Gorilla gorilla gorilla (Western lowland gorilla)
Phosphatidylinositol 3-kinase catalytic subunit type 3 UniProtKBInterProInteractive Modelling
887 aa; Sequence (Fasta) ;
4 identical sequences: Homo sapiens: Q8NEB9; Pan troglodytes: A0A6D2WQM8, A0A2I3SV31; Pan paniscus: A0A2R9AAE5
It is possible new templates exist for this target since these models were created.
Available Structures
23 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| human complex II-BATS bound to membrane-attached Rab5a-GTP |
Heteromer P20339; Q14457; Q8NEB9; Q99570; Q9P2Y5; | 100.0 | 1×GTP; 1×MG; | |||
| Structure of human PI3KC3-C1 complex |
Heteromer Q14457; Q6ZNE5; Q8NEB9; Q99570; | 100.0 | 1×ADP; | |||
| Structure of human ULK1C:PI3KC3-C1 supercomplex |
Heteromer Q14457; Q6ZNE5; Q8NEB9; Q8TDY2; Q99570; | 100.0 | ||||
| Structure of VPS34 LIR motif (S249E) bound to GABARAP | homo-3-mer | 91.67 | 3×PGE; | |||
| Structure of VPS34 LIR motif bound to GABARAP | homo-3-mer | 100.0 | 6×SO4; 6×EDO; 6×GOL; | |||
| Structure-based exploration of selectivity for ATM inhibitors in Huntingtons disease | monomer | 99.1 | 1×OZ8; | |||
| Optimization of potent and selective ATM inhibitors suitable for a proof-of-concept study in Huntin… | monomer | 99.1 | 1×H2E; | |||
| Crystal structure of VPS34 in complex with inhibitor SB02024 | monomer | 100.0 | 1×A1H4E; 2×PEG; 1×IMD; 3×DMS; 1×GOL; | |||
| Crystal structure of human PIK3C3 in complex with 3-[4-(4-Morpholinyl)thieno[3,2-d]pyrimidin-2-yl]-… | monomer | 100.0 | 1×AJZ; 2×CL; 1×GOL; | |||
| Human PIK3C3 crystal structure | monomer | 100.0 | ||||
| Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4… | monomer | 100.0 | 2×NA; 1×JXM; | |||
| CRYSTAL STRUCTURE OF VPS34 IN COMPLEX WITH SAR405. | monomer | 100.0 | 4×SO4; 1×1TT; | |||
| Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4… | monomer | 100.0 | 1×EUT; | |||
| Structure of the VPS34 kinase domain with compound 14 | monomer | 100.0 | 3×NA; 1×7IH; 1×EDO; 2×GOL; | |||
| Structure of the VPS34 kinase domain with compound 14 | monomer | 100.0 | 1×GOL; 1×7IK; | |||
| Structure of the VPS34 kinase domain with compound 5 | monomer | 100.0 | 1×7IQ; 2×GOL; 4×NA; | |||
| Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4… | monomer | 100.0 | 3×SO4; 1×RBQ; | |||
| Crystal structure of VPS34 in complex with (2S)-8-((3R)-3- Methylmorpholin-4-yl)-1-(3-methyl-2-oxo-… | monomer | 100.0 | 1×RBQ; | |||
| Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4… | monomer | 100.0 | 2×SO4; 1×7A5; | |||
| Discovery of (2S)-8-((3R)-3-Methylmorpholin-4-yl)-1-(3-methyl-2-oxo- butyl)-2-(trifluoromethyl)-3,4… | monomer | 100.0 | 1×SO4; 1×GOL; 1×UJB; | |||
| The structure of human vacuolar protein sorting 34 catalytic domain bound to MES | monomer | 100.0 | 1×MES; 1×PG4; 1×DMS; 4×PEG; 1×GOL; 4×CL; 3×K; | |||
| The crystal structure of Human VPS34 in complex with a selective and potent inhibitor | monomer | 100.0 | 1×5QS; 1×NA; | |||
| The crystal structure of Human VPS34 in complex with PIK-III | monomer | 100.0 | 1×GOL; 1×2UG; | |||
4 SWISS-MODEL models
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7bl1.1.B | monomer | 0.66 | 100.00 | |||
| 6gvg.1.A | monomer | 0.55 | 27.39 | |||
| 6g6w.1.A | monomer | 0.54 | 28.83 | |||
| 6c1s.1.A | monomer | 0.53 | 28.49 | |||